Major global cannabis exporters cannot tap into a common regulatory pathway to European markets. Cannabis is a massive opportunity, but marketing cannabis products in the diverse European market is a complex challenge. Peter Kohut at Arriello explains that although the European medical cannabis market is complex, this is not a barrier to entry to a market that is becoming increasingly attractive to major pharma players.